Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 1998

View Archived Issues

Dopamine transporter ligand shows potential in cocaine abuse

TAC-101 potently inhibits liver metastasis and prolongs survival in animal models

Study reports efficacy without side effects of new antitumor antibiotic FK-317

Locally applied fusafungine for rhinitis and sinusitis

Bioject enters vaccine delivery agreement with Merck

Cambridge NeuroScience and Boehringer Ingelheim end Cerestat collaboration

Genzyme General and Pharming to collaborate on Pompe's disease treatment

Pasteur Merieux Connaught, Cistron Biotechnology collaborate on vaccine adjuvant development

First demonstration of efficacy for PDT in treating autoimmune disorders

Another U.S. center begins inoculating volunteers with AIDSVAX

New antiischemic agent put on the developmental track at Otsuka

Yamanouchi identifies NK1 antagonist with good antiasthmatic activity

Invitation to access the ongoing telesymposium on rheumatoid arthritis therapies

Lilly describes several further series of estrogen receptor modulators

Canadian researchers discover potent new taxane

Modulators of MDR described by Xenova

Pola discloses new antifungal agents

Wakunaga researchers patent new antiplatelet agents

Onconase clinical program update

Trega identifies lead compounds in R&D collaboration with Ono

Phase II trial of Avicine in prostate cancer announced

Singulair introduced in Germany for asthma

Another European launch for Viracept

BIBN-99 improves cognition independent of effects on sleep

H3 receptor blockade with GT-2227 increases wakefulness without subsequent hypersomnolence

Zaleplon not associated with residual sedation, even following middle-of-the-night administration

In vitro and in vivo studies with VX-497 reported at transplant congress

Promising immunosuppressive activity reported for KF-20444

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...